Intestine and Lower Gastrointestinal Tract · 12 February 2025

Multidisciplinary tumor board significantly alters colorectal cancer management

In a study involving 1,150 colorectal cancer cases, a multidisciplinary tumor board (MDTB) led to a 28.3% modification rate in treatment plans post-discussion. Specific changes included a 24.1% alteration in radiological assessments, a 36.1% change in surgical strategies, and a 31.9% adjustment in radiotherapy recommendations. The findings underscore the MDTB’s vital role in enhancing treatment accuracy for colorectal cancer, addressing discrepancies in evaluations across various specialties.

Journal Article by Schietroma F, Bensi M (…) Salvatore L et 30 al. in Clin Colorectal Cancer

read the whole article in Clin Colorectal Cancer

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

The latest stitches

Br J Surg5 Nov 2026

Combined vs Staged Resection for Rectal Cancer Liver Metastases

Combined and staged surgery had similar complication rates and survival in a French national cohort.

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

Lancet4 Nov 2026

Colorectal cancer: shorter chemo, fewer side effects

A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.

All papers in Intestine and Lower Gastrointestinal Tract →